MEGAN WELTY: Open Payments
NPI 1144955972 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 25 payments from 8 companies in 2025. Trend: 2023 $304 · 2024 $1,499 · 2025 $767
Food & beverage: $499Travel & lodging: $268
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $341 |
| Lilly USA, LLC | 9 | $167 |
| Novo Nordisk Inc | 6 | $124 |
| SANOFI-AVENTIS U.S. LLC | 2 | $41 |
| BETA BIONICS, INC. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Sequel Med Tech, LLC | 1 | $18 |
Products named: MINIMED 780G, MOUNJARO, Ozempic, JARDIANCE, TZIELD, iLet Bionic Pancreas, Wegovy, Dexcom G6 Transmitter.
Industry payments across MD — which companies pay providers there.
